Telix Pharmaceuticals (ASX:TLX) said it has opened a cyclotron facility, Telix Manufacturing Solutions, in Yokohama, Japan, according to a Thursday statement by the company.
The facility will support commercial and clinical supply as well as research and development for Telix's pipeline of radiopharmaceutical products, including Zircaix, Illuccix, and Pixclara, the statement said.